Contrasting Medical Properties Trust (MPT) & Its Peers

Medical Properties Trust (NYSE:MPT) is one of 111 public companies in the “REIT – EQTY TRUST – OTHER” industry, but how does it contrast to its rivals? We will compare Medical Properties Trust to related businesses based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.

Valuation & Earnings

This table compares Medical Properties Trust and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Medical Properties Trust	$972.02 million	-$277.05 million	-11.91
Medical Properties Trust Competitors	$1.58 billion	$198.35 million	29.75

Medical Properties Trust’s rivals have higher revenue and earnings than Medical Properties Trust. Medical Properties Trust is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Medical Properties Trust has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Medical Properties Trust’s rivals have a beta of 1.20, meaning that their average stock price is 20% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Medical Properties Trust and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Properties Trust	2	2	2	0	2.00
Medical Properties Trust Competitors	2342	7941	8274	277	2.34

Medical Properties Trust currently has a consensus target price of $6.75, suggesting a potential upside of 23.18%. As a group, “REIT – EQTY TRUST – OTHER” companies have a potential upside of 8.67%. Given Medical Properties Trust’s higher probable upside, analysts plainly believe Medical Properties Trust is more favorable than its rivals.

Profitability

This table compares Medical Properties Trust and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medical Properties Trust	-28.50%	-5.87%	-1.85%
Medical Properties Trust Competitors	-0.08%	1.32%	0.82%

Dividends

Medical Properties Trust pays an annual dividend of $0.36 per share and has a dividend yield of 6.6%. Medical Properties Trust pays out -78.3% of its earnings in the form of a dividend. As a group, “REIT – EQTY TRUST – OTHER” companies pay a dividend yield of 4.6% and pay out 233.5% of their earnings in the form of a dividend. Medical Properties Trust is clearly a better dividend stock than its rivals, given its higher yield and lower payout ratio.

Insider & Institutional Ownership

71.8% of Medical Properties Trust shares are owned by institutional investors. Comparatively, 75.9% of shares of all “REIT – EQTY TRUST – OTHER” companies are owned by institutional investors. 1.3% of Medical Properties Trust shares are owned by insiders. Comparatively, 5.9% of shares of all “REIT – EQTY TRUST – OTHER” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Medical Properties Trust rivals beat Medical Properties Trust on 11 of the 15 factors compared.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.